Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Rating) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,500 shares, a decrease of 94.0% from the February 28th total of 24,900 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average […]
Should You Buy or Sell Anebulo Pharmaceuticals Stock? Get The Latest ANEB Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, NY / ACCESSWIRE / February 14, 2023 / Sidoti & Company, LLC announces that its two spring conferences are now open for registration. The March Virtual Small-Cap Conference will take place on